New AI model can identify neuroanatomical regions vulnerable to age-related changes

The aging brain undergoes structural and cellular changes that can impact function and increase susceptibility to neurodegenerative disorders like Alzheimer’s disease.

Biotech’s IPO outlook for the rest of the year sours in wake of war, broader industry struggles

Forget IPOs. Biotech insiders expect to see a handful of reverse mergers before the end of the year, similar to Wednesday’s handshake between Nasdaq-listed Graphite

November 17, 2023

Can machine learning algorithms identify patients at risk of a delay in starting cancer treatment?

Multi-level machine learning models for estimating the risk of delay between cancer diagnosis and treatment initiation in a large group of cancer patients.

August 17, 2023

A plot to solve the ‘whack-a-mole’ of drug discovery

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.